To examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among chronic liver disease (CLD) patients, with a focus on CAM therapies with the greatest potential for hepatotoxicity and interactions with conventional treatments. There is some evidence that patients with CLD commonly use CAM to address general and CLD-specific health concerns.
- Chronic liver disease
- Complementary and alternative medicine
ASJC Scopus subject areas